![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DISC DYNAMICS INC. RECEIVES APPROVAL TO BEGIN U.S. CLINICAL TRIAL OF ITS DASCOR DISC ARTHROPLASTY SYSTEM
DISC DYNAMICS INC. RECEIVES APPROVAL TO BEGIN U.S. CLINICAL TRIAL OF ITS DASCOR DISC ARTHROPLASTY SYSTEM
August 2, 2006
Disc Dynamics Inc. announced it has received U.S. Food and Drug Administration (FDA) approval to commence a clinical study of its DASCOR Disc Arthroplasty System. DASCOR is a catheter-based, minimally invasive nucleus replacement technology
designed to treat lower back pain associated with degenerative disc disease.
Yahoo
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct